MIRA INFORM REPORT

 

 

Report Date :

21.03.2014

 

IDENTIFICATION DETAILS

 

Name :

WATSON PHARMA PRIVATE LIMITED

 

 

Registered Office :

21-22, Kalpataru Square, Kondivita Off Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

21.10.2005

 

 

Com. Reg. No.:

11-156968

 

 

Capital Investment / Paid-up Capital :

Rs. 550.025 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2005PTC156968

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMW02844C

 

 

PAN No.:

[Permanent Account No.]

AAACW6074D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Importer and Exporter of Drugs and Pharmaceuticals.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (57)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 20000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having fine track record.

 

Fundamentals of the company is decent. Financial position of the company is strong and healthy. There are no external borrowing recorded by the company.

 

Trade relation reported to be fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

 The company can be considered normal for business dealing at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INDIAN ECONOMIC OVERVIEW

 

State-run banks hired nearly 300000 personnel including more than 94000 officers in the last four years, according to the Indian Banks Association. A study by trade lobby Assocham in September 2013 indicated that banks would need 800000 people in the next six years. It estimated that state-run lenders alone would hire 50000 people in 2013/14.

 

The Competition Commission of India plans to issue final orders within a broad time-frame of one year in matters where it decides to carry out detailed investigations. The number of complaints received by the watchdog which keeps tabs on unfair trade practices in the marketplace.

 

The government has detected custom tax evasion totaling around Rs 37920 mn in 14 states until December. Maharashtra topped the list of Rs 14190 mn followed by Andhra Pradesh at Rs 8140 mn, Gujarat Rs 5240 mn, Karnataka Rs 1670 mn and Tamilnadu Rs 1610 mn.

 

Connaught Place in New Delhi slipped four notches to become the world’s eighth most expensive office locations. London’s West End is the world’s most expensive office market.

 

There are 4.072 mn number of high value spenders under the scanner of the income tax department. The income tax department has information that they have made cash deposits announcing to Rs 1 mn or more in their savings bank accounts in the current financial year. It plans to check potential evasion before the closing of the financial year on March 31.

 

Estimated pharmaceutical sales in the country for 2016 is $ 27 bn. It is 14.4 per cent higher than a year ago. The life sciences and health care industry is up against challenges such as quality management, says a recent Deloitte report.

 

The gross non-performing assets of listed banks rose 35.2 % to Rs 2.43 lakh crore during the first three months of the financial year. In absolute terms, the 40 listed banks added Rs 3386 crore to their gross NPAs in nine months with the State Bank of India leading with the State Bank of India leading with an accretion of Rs 16610 crore.

 

The inflow of smuggled gold doubled in 2013 following restrictions to curb the supply from official channels to contain the current account deficit. China surpassed India in the demand for gold for the first time in 2013 due to liberalization of gold trading norms by its local governments.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Anand Kalani

Designation :

Accounts Manager

Contact No.:

91-22-66886700

Date :

19.03.2014

 

 

LOCATIONS

 

Registered Office :

21-22, Kalpataru Square, Kondivita Off Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra, India 

Tel. No.:              

91-22-66886700

Fax No.:

91-22-66886799

E-Mail :

rajesh.sharma@watsonpharm.co.in

sekhchem@bom3.vsnl.net.in

muralidharan.cs@watsonpharma.co.in

shivshanker.shenoy@watsonpharm.co.in

vishal.kulkarni@watsonpharm.co.in

manoj.ehalve@watsopharm.co.in

Website :

www.watson.com

 

 

DIRECTORS

 

As on: 24.06.2013

 

Name :

Mr. David Adam Irving Buchen

Designation :

Director

Address :

1967, LA France Avenue, South Pasadena, California – 91030, United States of America

Date of Birth/Age :

22.06.1964

Date of Appointment :

21.10.2005

DIN No.:

00839184

 

 

Name :

Patrick Gerard Brunner

Designation :

Director

Address :

10231, Key Plum ST, Plantation, Florida – 333248265, United States of America

Date of Birth/Age :

13.06.1963

Date of Appointment :

20.05.2010

DIN No.:

03024470

 

 

Name :

Mr. Muralidharan Sundaresan Chinnadharavaram

Designation :

Director

Address :

302 B Wing, Avalon Building, Hirenandani Garden, Powai, Mumbai – 400 076, Maharashtra, India

Date of Birth/Age :

05.02.1963

Date of Appointment :

20.05.2010

DIN No.:

00014740

 

 

Name :

Ronald Jefferey Morrod

Designation :

Managing Director

Address :

Flat No. 3rd and 4th, 1st and 2nd Floor, Unit No. 3, Narain Terraces, Union Park Road, Pali Hill, Bandra (West), Mumbai – 400 050, Maharashtra, India

Date of Birth/Age :

20.06.1957

Date of Appointment :

03.08.2010

DIN No.:

03139797

 

 

Name :

Mr. Jayant Shyam Sunder Bapna

Designation :

Director

Address :

6 Cutler CT, Suffern, New York 10901, United States of America

Date of Birth/Age :

17.07.1958

Date of Appointment :

23.05.2011

DIN No.:

03511093

 

 

Name :

Mr. Robert Allan Stewart

Designation :

Director

Address :

Heritage Village VIII, 4 Quail Run BLK 47.02 LT 1.02 Randolph New Jersey - 07869, United States of America

Date of Birth/Age :

03.05.1967

Date of Appointment :

23.05.2011

DIN No.:

03515778

 

 

Name :

Mr. Philip Abraham Biju

Designation :

Director

Address :

Supreme Mill Tower, Flat 204, Alto Monte, Margao – 403 601, Goa, India

Date of Birth/Age :

04.11.1969

Date of Appointment :

23.05.2011

DIN No.:

03515838

 

 

KEY EXECUTIVES

 

Name :

Mr. Anand Kalani

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 24.06.2013

 

Names of Shareholders

 

No. of Shares

Watson Laboratories Inc, USA

 

55002460

Watson Pharma Inc, Parsippany

 

1

 

 

 

Total

 

55002461

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 24.06.2013

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

100.00

 

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Importer and Exporter of Drugs and Pharmaceuticals.

 

 

Products :

Item Code No.

Product Description

2942 00 90

Imiquimod Bulk Drug

3004 90 69

Carisoprodol Tablets

3004 90 39

Minocycline Capsules

3004 39 12

Other – Prednisone Tablets

3004 90 71

Other – Lisinopril Tablets

 

PRODUCTION STATUS (AS ON : 31.12.2011)

 

Particulars

Unit

Installed Capacity

Actual Production

Drugs and Pharmaceuticals

 

 

 

Active Pharmaceutical Ingredients

Tones

112

86

Formulations – Tablets and Capsules

Million Nos.

3000

2855

 

*Licensed Capacity is not applicable as industrial licensing has been abolished in respect of these products vide Notification No. SO-477(E) dated 25th July, 1991 as amended vide Press Release Note No. 4 of the 1994 series dated 25th October, 1994 issued by the Department of Industrial Development, Ministry of Industry, Government of India

 

'@Installed Capacity (Active Pharmaceutical Ingredients at Ambernath plant on triple shift basis, Formulations at Goa plant on triple shift basis and Formulations at Ambernath plant on single shift basis) being a technical matter, is certified by the management and relied upon by the auditors.

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

  • HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel W, Mumbai - 400013, Maharashtra, India
  • Standard Chartered Bank, Mumbai Branch, 90 Mg Road, Mumbai - 400001, Maharashtra, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Lovelock and Lewes

Chartered Accountants

Address :

252, Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai – 400 028, Maharashtra, India

PAN No.:

AABFL5878L

 

 

Ultimate Holding Company :

  • Watson Pharmaceuticals, Inc., USA

 

 

Holding Company :

  • Watson Laboratories, Inc., USA

 

 

Fellow Subsidiaries :

  • Arrow Farmaceutica, Brazil
  • Arrow International Limited, Malta
  • Arrow No. 7 Limited, UK
  • Arrow Pharma (Malta) Limited, Malta
  • Cobalt Pharmaceuticals Inc., Canada
  • Specifar Pharmaceuticals, Greece
  • Watson Pharma (PTY) Limited., South Africa
  • Spirit Pharmaceuticals, Australia

 

 

CAPITAL STRUCTURE

 

As on: 24.06.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

75000000

Equity Shares

Rs.10/- each

Rs. 750.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

55002461

Equity Shares

Rs.10/- each

Rs. 550.025 Millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.12.2012

 

31.12.2011

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

550.025

550.025

(b) Reserves & Surplus

 

4,614.921

3,939.668

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

5,164.946

4,489.693

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

545.193

(b) Deferred tax liabilities (Net)

 

258.658

196.111

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

25.677

14.029

Total Non-current Liabilities (3)

 

284.335

755.333

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

733.011

735.699

(c) Other current liabilities

 

766.042

794.008

(d) Short-term provisions

 

32.448

9.686

Total Current Liabilities (4)

 

1,531.501

1,539.393

 

 

 

 

TOTAL

 

6,980.782

6,784.419

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

3,268.962

2,764.305

(ii) Intangible Assets

 

66.440

46.988

(iii) Capital work-in-progress

 

223.350

482.876

(iv) Intangible assets under development

 

19.309

3.879

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

478.578

510.213

(e) Other Non-current assets

 

1.439

1.334

Total Non-Current Assets

 

4,058.078

3,809.595

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

226.795

50.238

(b) Inventories

 

2,084.216

1,766.609

(c) Trade receivables

 

394.044

296.462

(d) Cash and cash equivalents

 

107.836

590.381

(e) Short-term loans and advances

 

109.263

267.000

(f) Other current assets

 

0.550

4.134

Total Current Assets

 

2,922.704

2,974.824

 

 

 

 

TOTAL

 

6,980.782

6,784.419

 

 

SOURCES OF FUNDS

 

 

 

31.12.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

550.025

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

3496.194

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

4046.219

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

911.000

TOTAL BORROWING

 

 

911.000

DEFERRED TAX LIABILITIES

 

 

297.753

 

 

 

 

TOTAL

 

 

5254.972

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

2991.737

Capital work-in-progress

 

 

102.923

 

 

 

 

INVESTMENT

 

 

50.002

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
1028.204

 

Sundry Debtors

 
 
456.415

 

Cash & Bank Balances

 
 
400.327

 

Other Current Assets

 
 
0.000

 

Loans & Advances

 
 
727.996

Total Current Assets

 

 

2612.942

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 
 
448.885

 

Other Current Liabilities

 
 
17.317

 

Provisions

 
 
36.430

Total Current Liabilities

 

 

502.632

Net Current Assets

 
 
2110.310

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

5254.972

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.12.2012

31.12.2011

31.12.2010

 

SALES

 

 

 

 

 

Income

6990.709

5453.652

4975.116

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

6990.709

5453.652

4975.116

 

 

 

 

 

Less

EXPENSES

 

 

 

Office Expenses

5614.184

4485.290

3822.863

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

5614.184

4485.290

3822.863

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

1376.525

968.362

1152.253

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

11.996

13.473

12.946

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

1364.529

954.889

1139.307

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

360.755

322.128

287.531

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

1003.774

632.761

851.776

 

 

 

 

 

 

Prior Period Items

7.316

30.616

0.000

 

 

 

 

 

Less

TAX                                                                  (H)

321.205

158.670

195.687

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

675.253

443.475

656.089

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2131.677

1688.202

1032.113

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

2806.930

2131.677

1688.202

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

NA

NA

3715.991

 

 

Freight and Insurance

NA

NA

6.085

 

 

Income from Products Development Activities

NA

NA

1002.310

 

 

Recovery towards Manufacturing Site Transfer Activities

NA

NA

174.026

 

 

License Fees

NA

NA

10.138

 

 

Exchange Gain (Net)

NA

NA

12.427

 

TOTAL EARNINGS

NA

NA

4920.977

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

NA

1842.562

 

 

Capital Goods

NA

NA

186.797

 

 

Stores

NA

NA

72.402

 

TOTAL IMPORTS

NA

NA

2101.761

 

 

 

 

 

 

Earnings Per Share (Rs.)

12.28

8.06

11.93

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2012

31.12.2011

31.12.2010

PAT / Total Income

(%)

9.66

8.13

13.19

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.90

10.05

15.20

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.19

0.15

0.21

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.12

0.22

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.91

1.93

5.20

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.12.2011

31.12.2012

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

550.025

550.025

Reserves & Surplus

3,939.668

4,614.921

Net worth

4,489.693

5,164.946

 

 

 

long-term borrowings

545.193

0.000

Short term borrowings

0.000

0.000

Total borrowings

545.193

0.000

Debt/Equity ratio

0.121

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.12.2010

31.12.2011

31.12.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

4,975.116

5,453.652

6,990.709

 

 

9.619

28.184

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.12.2010

31.12.2011

31.12.2012

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

4,975.116

5,453.652

6,990.709

Profit

656.089

443.475

675.253

 

13.19%

8.13%

9.66%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG-TERM DEBT DETAILS

 

Particulars 

31.12.2012

31.12.2011

31.12.2010

 

 

 

 

Current maturities of long-term debt

549.890

545.193

0.000

 

 

 

 

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on

31.12.2012

As on

31.12.2011

Long term borrowings

 

 

Term loans from others

0.000

545.193

 

 

 

Total

0.000

545.193

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10163588

23/06/2009

250,000,000.00

HDFC BANK LIMITED

HDFC BANK HOUSESENAPATI BAPAT MARG, LOWER PAREL W
, MUMBAI, MAHARASHTRA - 400013, INDIA

A64359128

 

 

FIXED ASSETS

 

Intangible Assets:

  • Technical know-how
  • Computer Software
  • Others

Tangible Assets:

  • Leasehold Land
  • Buildings
  • Plant and Machinery
  • Office Equipments
  • Computers
  • Laboratory Equipment
  • Furniture and Fittings
  • Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.13

UK Pound

1

Rs. 101.17

Euro

1

Rs. 84.59

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Report Prepared by :

DPH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

57

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.